# Fougera Pharmaceuticals  Inc. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/fougera-pharmaceuticals-inc/3868bd8e-22c5-4998-85b0-38e0df2d115b

> Inspection records and compliance data for Fougera Pharmaceuticals  Inc. in Melville, New York. Access full analysis and detailed observations.

---

## Details

- Name: Fougera Pharmaceuticals  Inc.
- FEI Number: 2432435
- City: Melville
- State: New York
- Country Name: United States
- Address Line 1: 60 Baylis Rd
- Zip Code: 11747
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [FDA Inspection 1226533 - Fougera Pharmaceuticals  Inc. - 2023-12-08](https://www.globalkeysolutions.net/records/fda_inspections/fougera-pharmaceuticals-inc/663ede67-d252-428d-b060-eb4721698054) — classification: No Action Indicated (NAI), source: FDA, date: December 8, 2023
- [FDA Inspection 1226533 - Fougera Pharmaceuticals  Inc. - 2023-12-08](https://www.globalkeysolutions.net/records/fda_inspections/fougera-pharmaceuticals-inc/c3bd4b73-eaad-4b83-838e-77e0ca43bf24) — classification: No Action Indicated (NAI), source: FDA, date: December 8, 2023
- [FDA Inspection 1177370 - Fougera Pharmaceuticals  Inc. - 2022-08-10](https://www.globalkeysolutions.net/records/fda_inspections/fougera-pharmaceuticals-inc/ab3524e1-b973-473e-824e-3219c4ccf027) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 10, 2022
- [FDA Inspection 1177370 - Fougera Pharmaceuticals  Inc. - 2022-08-10](https://www.globalkeysolutions.net/records/fda_inspections/fougera-pharmaceuticals-inc/942215a9-2995-4d80-942e-a67234992680) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 10, 2022
- [FDA Inspection 1099025 - Fougera Pharmaceuticals  Inc. - 2019-08-08](https://www.globalkeysolutions.net/records/fda_inspections/fougera-pharmaceuticals-inc/546938bb-ef9c-4665-9aa0-2440af4245aa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 8, 2019
- [FDA Inspection 1053495 - Fougera Pharmaceuticals  Inc. - 2018-05-29](https://www.globalkeysolutions.net/records/fda_inspections/fougera-pharmaceuticals-inc/9d8db8ab-279e-435c-98d6-0d139b95428a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 29, 2018
- [FDA Inspection 1053495 - Fougera Pharmaceuticals  Inc. - 2018-05-29](https://www.globalkeysolutions.net/records/fda_inspections/fougera-pharmaceuticals-inc/56a3f1d0-59d4-4c8e-99b9-0fb5d3252fab) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 29, 2018
- [FDA Inspection 992924 - Fougera Pharmaceuticals  Inc. - 2016-11-10](https://www.globalkeysolutions.net/records/fda_inspections/fougera-pharmaceuticals-inc/21e5f7db-3f03-406c-bb61-cde57ef5724d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 10, 2016
- [FDA Inspection 992924 - Fougera Pharmaceuticals  Inc. - 2016-11-10](https://www.globalkeysolutions.net/records/fda_inspections/fougera-pharmaceuticals-inc/716eab12-dbfe-43df-9dff-a1402c5ae9ee) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 10, 2016
- [FDA Inspection 908064 - Fougera Pharmaceuticals  Inc. - 2014-12-23](https://www.globalkeysolutions.net/records/fda_inspections/fougera-pharmaceuticals-inc/b4968208-702a-421e-98e0-32c8e3af823d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 23, 2014

## Related Companies

- [Particle Technology Group, LLC](https://www.globalkeysolutions.net/companies/particle-technology-group-llc/739b37e7-35ae-45aa-a515-a9d4d01fccb7)
- [Element Materials Technology Pharma USA LLC](https://www.globalkeysolutions.net/companies/element-materials-technology-pharma-usa-llc/d40408f6-37dd-44fb-8760-20aa927a8e8c)
- [QualTech Laboratories, Inc.](https://www.globalkeysolutions.net/companies/qualtech-laboratories-inc/7cf9f443-ef52-4807-8a49-2322da5f4133)
- [American Regent, Inc.](https://www.globalkeysolutions.net/companies/american-regent-inc/9e5e908d-150e-4cb7-9d39-ab0eef6c4c0e)
- [Eurofins Biolab S.r.l.](https://www.globalkeysolutions.net/companies/eurofins-biolab-srl/3f1b31b8-2af2-4083-8cdb-3e0fbf994b22)
- [Eurofins BioPharma Product Testing Columbia, LLC](https://www.globalkeysolutions.net/companies/eurofins-biopharma-product-testing-columbia-llc/b616a9a6-094c-4f02-80ba-59880916eaf2)
- [R.D. Laboratories Inc.](https://www.globalkeysolutions.net/companies/rd-laboratories-inc/b75c7a7e-9454-4127-add6-6107232599f1)
- [SGS Institut Fresenius GmbH](https://www.globalkeysolutions.net/companies/sgs-institut-fresenius-gmbh/9053e3ca-148d-4280-ac0d-789a34084eb8)
- [Quinta Analytica s.r.o.](https://www.globalkeysolutions.net/companies/quinta-analytica-sro/f26231ff-818d-4ba0-b952-72115b356982)
- [LabCorp Early Development Laboratories Limited.](https://www.globalkeysolutions.net/companies/labcorp-early-development-laboratories-limited/4f0ec845-b78a-440d-b747-30df285f57ad)